We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Deadliest Cancers Receive the Least Amount of Research Funding

News   Jul 22, 2019 | Original story from Northwestern Medicine

 
Deadliest Cancers Receive the Least Amount of Research Funding

A comparison of the four highest- and lowest-funded types of cancers. Credit: Northwestern University

 
 
 

RELATED ARTICLES

New Markers for Triple Negative Breast Cancer

News

Two biomarkers – a 44-gene DNA Damage Response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs) – can serve as prognostic markers in people diagnosed with triple negative breast cancer, according to a new study.

READ MORE

Test Predicts Chance of Living More Than a Year on Targeted Breast Cancer Treatment

News

A new test could pick out women with advanced breast cancer who are likely to benefit from a novel targeted therapy for more than a year.

READ MORE

Bile Duct Biomarker? Protein May Help Predict Outcomes for Patients With Lethal Cancer

News

Researchers have discovered how a gene-repressing protein could help to predict survival outcomes in patients with a malignant form of bile duct cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE